Q&A with John Bothmer, Clinical Translation Medicine Fellow at Angelini Pharma To further explore the scientific, regulatory and operational complexity behind FirstinHuman trials , we spoke with John Bothmer, Clinical Translation Medicine Fellow within the Global Clinical Development & Clinical Operations department at Angelini Pharma , about the role these studies play in clinical development and the safeguards that support this transition from preclinical research to human investigation
This enhances athletic productivity
Staresinic M, Sebecic B, Patrlj L, Jadrijevic S, Suknaic S, Perovic D, et al
PT-141 has been shown to work for men who dont respond to Viagra or other currently available drugs, and it is one of the first therapies to successfully treat sexual dysfunction in female patients
Studies examining whether combined effects are additive or synergistic would address this gap